IPO Boutique

LB Pharmaceuticals Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on LB Pharmaceuticals Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
LB Pharmaceuticals Inc.LBRX -
NASDAQ
$14.00-$16.00 $15.00 $19.0019 million9/11/2025
Leerink, Piper Sandler, Stifel
Co-Manager(s):
Health Care
Filing(s):

Filed 2025-08-22
Terms Added 2025-09-08



LB Pharmaceuticals Inc. Quote & Chart - Click for current quote - LBRX

About LB Pharmaceuticals Inc. (adapted from LB Pharmaceuticals Inc. prospectus):
They are a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "LBRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2026 IPO Boutique. All Rights Reserved